News
New prescriptions for Wegovy among teenagers increased by 50% between 2023 and 2024, according to a June 3 report from healthcare data company Truveta. To analyze GLP-1 utilization trends among ...
ReShape Lifesciences gains MDR and UKCA certification for all EU and UK devices, meeting strict regulatory standards well ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
Rising teen obesity prompts a surge in Novo Nordisk's Wegovy usage among adolescents, with prescriptions climbing 50% in 2024 ...
Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...
Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced on Monday that its experimental drug, when combined with Novo ...
William Tong has taken legal action against two online distributors, Triggered Brand and Made In China, for allegedly selling research-grade GLP-1 weight loss drugs directly to Connecticut consumers ...
Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results